The latest Bench to Bedside column reviews new guidance on the treatment of drug-susceptible and drug-resistance Mycobacterium tuberculosis infections.
Lindsey M. Childs-Kean, PharmD, MPH, BCPS
Advertisement
Childs-Kean is a clinical associate professor at the University of Florida College of Pharmacy in Gainesville, FL.
Articles by Lindsey M. Childs-Kean, PharmD, MPH, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Nearly 1 in 5 Urinary Tract Infections in Southern California Linked to Contaminated Meat
2
Moderna Discontinues Development of Vaccine for Congenital CMV After Not Meeting Primary Efficacy Endpoint
3
High Continued Adherence of Lenacapavir in Individuals Who Use Substances and Alcohol
4
Risk Stratification, Testing, and Treatment in Recurrent Clostridioides difficile
5
